Summary
A simple formula is presented for estimating the systemic availability of an orally administered drug from the relative total clearance (oral clearance) when renal clearance forms an important part of total clearance.
Hepatic plasma flow is used in the equation and is represented by an average value taken from the literature. The formula is applied to data for cimetidine discussed in the literature. A further application is demonstrated for a drug under development for which an intravenous formulation was not available.
It is possible to estimate the upper and lower limit of availability if some information on the amount of drug absorbed is available.
Similar content being viewed by others
References
Gibaldi M, Boyes RN, Feldman S (1971) Influence of first-pass effect on availability of drugs on oral administration. J Pharm Sci 60: 1338–1340
Grahnen A, von Bahr C, Lindström B, Rosin A (1979) Bioavailability and pharmacokinetics of cimetidine. Eur J Clin Pharmacol 16: 335–340
Grahnen A (1984) Cimetidine bioavailability and variable renal clearance. Eur J Clin Pharmacol 27: 623–624
Øie S, Jung D (1979) Bioavailability under variable renal clearance conditions. J Pharm Sci 68: 128–129
Somogyi A, Rohner HG, Gugler R (1980) Pharmacokinetics and bioavailability of cimetidine in gastric and duodenal ulcer patients. Clin Pharmacokinet 5: 84–94
Somogyi A, Eichelbaum M, Gugler R (1982) Prediction of bioavailability for drugs with a high first-pass effect using oral clearance data. Eur J Clin Pharmacol 22: 85–90
Vaughan DP, Trainor A (1975) A general equation for the ratio of the areas below the blood or plasma concentration time-curves following intravenous and oral drug administration and its application to inter-subject variation in drug elimination. Br J Clin Pharmacol 2: 239–250
Wilkenson GR, Shand DG (1975) A physiological approach to hepatic drug clearance. Clin Pharmacol Ther 18: 377–390
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Brockmeier, D. Estimating reduced availability due to first pass elimination from relative total clearance and renal clearance. Eur J Clin Pharmacol 35, 397–400 (1988). https://doi.org/10.1007/BF00561371
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00561371